Ackman Amassed Allergan Stake Under Botox Maker’s Radar

Bill Ackman’s Pershing Square Capital Management LP amassed almost 10 percent of Allergan Inc. in less than two months without raising many eyebrows at the Botox-maker he’s now targeting in a hostile takeover bid.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.